Gallic acid, a dietary polyphenolic components, blunts the inhibition of platelet COX-1 by aspirin: Preliminary in-vitro findings [4]

Thrombosis and Haemostasis

Volumn 97, Issue 6, 2007, Pages 1054-1056

  Crescente, Marilena ^a   Cerletti, Chiara ^a   de Gaetano, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; GALLIC ACID; SALICYLIC ACID; THROMBOXANE B2;

CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; FOOD; FOOD ANALYSIS; FOOD COMPOSITION; FOOD DRUG INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ASPIRIN; BLOOD PLATELETS; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD-DRUG INTERACTIONS; GALLIC ACID; HUMANS; PLATELET AGGREGATION; SALICYLIC ACID; THROMBOXANE B2;

EID: 34250658834     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-01-0056     Document Type: Letter

References (13)

1. Ohno Y, Fukuda K, Takemura G, et al. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999; 10: 845-851.
2. Appeldoorn CC, Bonnefoy A, Lutters BC, et al. Gallic acid antagonizes P-selectin-mediated platelet-leukocyte interactions: implications for the French paradox. Circulation 2005; 111: 106-112.
3. de Gaetano G, Cerletti C, Dejana E, et al. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. Circulation 1985; 72: 1185-1193.
4. Livio M, Del Maschio A, Cerletti C, et al. Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins 1982; 23: 787-796.
5. MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003; 361: 573-574.
6. Shahrzad S, Aoyagi K, Winter A, et al. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 2001; 131: 1207-1210.
7. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. J Am Med Assoc 2006; 296: 1255-1265.
8. Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599-2608.
9. Konishi Y, Hitomi Y, Yoshioka E. Intestinal absorption of p-coumaric and gallic acids in rats after oral administration. J Agric Food Chem 2004; 52: 2527-2532.
10. de Gaetano G, Cerletti C. Aspirin resistance: a revival of platelet aggregation tests? J Thromb Haemost 2003; 1: 2048-2061.
11. Maree AO, Fitzgerald DJ. Aspirin and coronary artery disease. Thromb Haemost 2004; 92: 1175-1181.
12. Szczeklik A, Musial J, Undas A, et al. Aspirin resistance. J Thromb Haemost 2005; 3: 1655-1662.
13. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-617.